S&P 500   2,998.54 (+0.09%)
DOW   26,803.76 (+0.06%)
QQQ   191.94 (+0.05%)
AAPL   242.61 (+1.10%)
FB   185.14 (+1.54%)
GOOGL   1,253.20 (+0.97%)
AMZN   1,761.92 (-0.22%)
NVDA   195.14 (-0.24%)
MU   44.57 (-0.20%)
BABA   168.62 (-0.75%)
GE   9.08 (+0.11%)
TSLA   254.71 (-0.34%)
AMD   31.42 (-0.32%)
T   37.80 (-1.00%)
NFLX   272.18 (+2.06%)
BAC   31.24 (+0.13%)
GILD   66.43 (+0.87%)
DIS   131.39 (-0.76%)
S&P 500   2,998.54 (+0.09%)
DOW   26,803.76 (+0.06%)
QQQ   191.94 (+0.05%)
AAPL   242.61 (+1.10%)
FB   185.14 (+1.54%)
GOOGL   1,253.20 (+0.97%)
AMZN   1,761.92 (-0.22%)
NVDA   195.14 (-0.24%)
MU   44.57 (-0.20%)
BABA   168.62 (-0.75%)
GE   9.08 (+0.11%)
TSLA   254.71 (-0.34%)
AMD   31.42 (-0.32%)
T   37.80 (-1.00%)
NFLX   272.18 (+2.06%)
BAC   31.24 (+0.13%)
GILD   66.43 (+0.87%)
DIS   131.39 (-0.76%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space
(ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 BELLUS HealthAnaptysBioRa PharmaceuticalsInnovivaEpizyme
SymbolN/ANASDAQ:ANABNASDAQ:RARXNASDAQ:INVANASDAQ:EPZM
Price Information
Current PriceN/A$38.19$46.15$10.90$10.89
52 Week RangeN/ABuyHoldN/ABuy
Analyst Ratings
Consensus RecommendationN/ABuyHoldN/ABuy
Consensus Price TargetN/A$102.86$48.20N/A$17.50
% Upside from Price TargetN/A169.33% upside4.44% upsideN/A60.70% upside
Trade Information
Market Cap$1.19 billion$1.02 billion$2.17 billion$1.11 billion$977.73 million
Beta1.551.51.341.422.37
Average Volume61,933437,0552,236,257660,441513,032
Sales & Book Value
Annual Revenue$30,000.00$5 million$2.50 million$261 million$21.70 million
Price / Sales0.00206.61867.804.2345.69
CashflowN/AN/AN/A$4.10 per shareN/A
Price / CashN/AN/AN/A2.66N/A
Book Value$0.25 per share$18.18 per share$4.92 per share$1.57 per share$2.94 per share
Price / Book0.002.109.386.943.70
Profitability
Net Income$-7,010,000.00$-61,660,000.00$-64,940,000.00$395.05 million$-123,630,000.00
EPSN/A($2.50)($2.06)$3.53($1.72)
Trailing P/E Ratio0.00N/AN/A3.09N/A
Forward P/E RatioN/AN/AN/A10.19N/A
P/E GrowthN/AN/AN/AN/AN/A
Net Margins-49,910.34%N/AN/A146.60%N/A
Return on Equity (ROE)-48.37%-16.61%-45.14%307.49%-54.00%
Return on Assets (ROA)-45.25%-15.75%-41.83%74.31%-43.79%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/AN/A0.02%1.57%0.03%
Current Ratio13.87%14.07%15.30%42.50%10.56%
Quick Ratio13.87%14.07%15.30%42.50%10.56%
Ownership Information
Institutional Ownership PercentageN/AN/A91.59%75.65%86.30%
Insider Ownership Percentage24.17%14.00%4.30%0.18%16.60%
Miscellaneous
Employees1078726124
Shares Outstanding159.12 million27.05 million47.01 million101.26 million91.04 million
Next Earnings Date11/13/2019 (Estimated)11/14/2019 (Estimated)11/6/2019 (Estimated)10/30/2019 (Estimated)11/1/2019 (Estimated)
OptionableNot OptionableOptionableOptionableOptionableOptionable
 BELLUS HealthAnaptysBioRa PharmaceuticalsInnovivaEpizyme

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel